BioXcel Therapeutics, Inc. Common Stock (BTAI) is a publicly traded Healthcare sector company. As of August 3, 2026, BTAI trades at $0.82 with a market cap of $24.95M and a P/E ratio of -0.18. BTAI moved +1.73% today. Year to date, BTAI is -47.19%; over the trailing twelve months it is -38.32%. Its 52-week range spans $0.74 to $9.26. Rallies surfaces BTAI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
BioXcel Therapeutics, Inc. Common Stock (BTAI) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BTAI moved +1.73% today.
| Metric | Value |
|---|---|
| Price | $0.82 |
| Market Cap | $24.95M |
| P/E Ratio | -0.18 |
| EPS | $-4.52 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.26 |
| 52-Week Low | $0.74 |
| Volume | 6.25K |
| Avg Volume | 0 |
| Revenue (TTM) | $680.00K |
| Net Income | $-75.33M |
| Gross Margin | 36.32% |
BTAI analyst coverage data. Average price target: $0.00.